Surgical implantmaker Surgalign, former executives charged by US SEC with accounting, disclosure fraud
MLex Summary: Surgalign Holdings agreed to pay $2 million to settle US Securities and Exchange Commission charges that the company concealed disappointing sales numbers by shipping future orders ahead of schedule to...To view the full article, register now.
Already a subscriber? Click here to view full article